Prophylaxis failure due to probable mefloquine resistant P. falciparum from Tanzania

Acta Tropica

Volumn 86, Issue 1, 2003, Pages 63-65

  Wichmann, O ^a   Betschart, B ^b   Loscher T ^a   Nothdurft, H D ^a   Sonnenburg, F V ^a   Jelinek, Tomas ^a,c  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF NEUCHÂTEL   (Switzerland)

^c Institute of Tropical Medicine   (Germany)

Author keywords

Drug resistance; Malaria prophylaxis; Mefloquine; Plasmodium falciparum; Tanzania

Indexed keywords

MALAQUICK; MEFLOQUINE;

BLOOD; DRUG RESISTANCE; MALARIA;

ADULT; AFRICA; ANTIBIOTIC RESISTANCE; ARTICLE; CASE REPORT; CHEMOPROPHYLAXIS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; FEVER; HEADACHE; HUMAN; MALARIA; MYALGIA; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; TREATMENT FAILURE; TROPHOZOITE;

ADULT; ANIMALS; ANTIMALARIALS; DRUG RESISTANCE; FEMALE; HUMANS; MALARIA, FALCIPARUM; MEFLOQUINE; PARASITEMIA; PLASMODIUM FALCIPARUM; TANZANIA; TRAVEL;

TANZANIA;

PLASMODIUM FALCIPARUM;

EID: 0242669956     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(03)00003-2     Document Type: Article

References (11)

1. Behrens R.H., Taylor R.B., Pryce D.I., Low A.S. Poor compliance to chemoprophylaxis as a major factor in malaria in travellers. J. Travel Med. 5:1998;88-90.
2. Brasseur P., Kouamouo J., Moyou-Somo R., Druilhe P. Multi-drug resistant falciparum malaria in Cameroon in 1987-1988. II. Mefloquine resistance confirmed in vivo and in vitro and its correlation with quinine resistance. Am. J. Trop. Med. Hyg. 46:1992;8-14.
3. Bruce-Chwatt L.J., Black R.H., Canfield C.J., Clyde D.F., Peters W., Wernsdorfer W. Chemotherapy of Malaria. 1981;205-210 Word Health Organization, Geneva.
4. Bygbjerg I.C., Schapira A., Flachs H., Gomme G., Jepsen S. Mefloquine resistance of falciparum malaria from Tanzania enhanced by treatment. Lancet. 1:1983;774-775.
5. Jelinek T., Grobusch M.P., Löscher T. Patterns of Plasmodium falciparum drug resistance in nonimmune travellers to Africa. Eur. J. Microbiol. Infect. Dis. 20:2001;284-286.
6. Lobel H.O., Varma J.K., Miani M., et al. Monitoring for mefloquine-resistant Plasmodium falciparum in Africa: Implications for travellers' health. Am. J. Trop. Med. Hyg. 59:1998;129-132.
7. Ooi W.W. Failure of mefloquine prophylaxis in East Africa. New Engl. J. Med. 324:1997;130.
8. Reyburn H., Behrens R.H., Warhurst D., Bradley D. The effect of chemoprophylaxis on the timing of onset of falciparum malaria. Trop. Med. Int. Health. 3:1998;281-285.
9. Schlagenhauf P. Mefloquin for malaria chemoprophylaxis 1992-1998: a review. J. Travel Med. 6:1999;122-133.
10. Steffen R., Heusser R., Machler R., et al. Malaria chemoprophylaxis among European tourists in tropical Africa: use, adverse reactions, and efficacy. Bull. WHO. 68:1990;313-322.
11. Wallace M.R., Sharp T.W., Smoak B., et al. Malaria among US troops in Somalia. Am. J. Med. 100:1996;49-55.